IL-1 Inhibition as Targeted Treatment for Rheumatoid Arthritis, Type 2 Diabetes
Researchers investigated the role of interleukin-1 inhibition in improving glycemic and inflammatory parameters in patients with rheumatoid arthritis and type 2 diabetes.